Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2014
10/09/2014WO2014165070A1 Substituted 2-azabicycles and their use as orexin receptor modulators
10/09/2014WO2014165044A1 Processes for the preparation of an apoptosis-inducing agent
10/09/2014WO2014164780A1 Fused tetracyclic bromodomain inhibitors
10/09/2014WO2014164771A1 Bromodomain inhibitors
10/09/2014WO2014164409A1 Inhibitors of human immunodeficiency virus replication
10/09/2014WO2014163147A1 Salt of pyrazoloquinoline derivative, and crystal thereof
10/09/2014WO2014163146A1 Pyridinylpyrazoloquinoline compound
10/09/2014WO2014162039A1 Protein kinase inhibitors
10/09/2014WO2014161808A1 Novel n-(2,3-dihydro-1h-pyrrolo[2,3-b]jpyridin-5-yl)-4- quinazolinamine and n-(2,3-dihydro-1h-indol-5-yl)-4- quinazolinamine derivatives as perk inhibitors
10/09/2014WO2014161799A1 Inhibitors of bruton's tyrosine kinase
10/09/2014US20140303372 Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
10/09/2014US20140303204 Modulators of cystic fibrosis transmembrane conductance regulator
10/09/2014US20140303192 Compounds and compositions for treating chemical warfare agent-induced injuries
10/09/2014US20140303186 Nitrogen-containing fused ring compounds as crth2 antagonists
10/09/2014US20140303177 Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitors
10/09/2014US20140303171 Hiv protease inhibitors
10/09/2014US20140303167 Cdk9 inhibitors in the treatment of midline carcinoma
10/09/2014US20140303164 Therapeutic compounds
10/09/2014US20140303163 Use of kinase inhibitors in preventing and treating inflammatory disorder
10/09/2014US20140303162 Azabicyclo compound and salt thereof
10/09/2014US20140303159 Macrocyclic flt3 kinase inhibitors
10/09/2014US20140303158 Fused heterocyclic compounds as ion channel modulators
10/09/2014US20140303156 Novel (6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
10/09/2014US20140303153 Novel inhibitor compounds of phosphodiesterase type 10a
10/09/2014US20140303150 Ingenol-3-acylates iii and ingenol-3-carbamates
10/09/2014US20140303144 Compounds and methods of treating hypertension
10/09/2014US20140303143 Benzoxazolinone compounds with selective activity in voltage-gated sodium channels
10/09/2014US20140303142 Azaindoles as janus kinase inhibitors
10/09/2014US20140303141 Triazolopyridine compounds
10/09/2014US20140303140 Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
10/09/2014US20140303121 Heterocyclic compounds and uses thereof
10/09/2014US20140301999 Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
10/08/2014EP2786995A1 Azaindoles useful as inhibitors of JAK and other protein kinases
10/08/2014EP2786986A2 Novel benzamide derivative and use thereof
10/08/2014EP2786435A1 Display
10/08/2014EP2785720A1 Heterocyclic amides compounds which are hdac6 inhibitors and used as anti-tumoral agents
10/08/2014EP2785715A1 Substituted pyridine derivatives as fabi inhibitors
10/08/2014EP2785695A1 New bicyclic dihydroisoquinoline-1-one derivatives
10/08/2014EP2785694A1 N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics
10/07/2014US8853427 Neprilysin inhibitors
10/07/2014US8853420 Compounds
10/07/2014US8853416 Chemical compounds
10/07/2014US8853403 Heterocyclic compound and light-emitting element, light-emitting device, lighting device, and electronic device using the same
10/07/2014US8853398 Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compound
10/07/2014US8853395 Process for the preparation of lurasidone hydrochloride
10/07/2014US8853391 Tricyclic azaindoles
10/07/2014US8853240 Compounds useful for the treatment of degenerative and inflammatory diseases
10/07/2014US8853235 Polymorphs and salts of a kinase inhibitor
10/07/2014US8853234 Quinolone analogs and methods related thereto
10/07/2014US8853226 Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
10/07/2014US8853221 Compounds of estrogen-related receptor modulators and the uses thereof
10/07/2014US8853219 Compounds and compositions for cognition-enhancement, methods of making, and methods of treating
10/07/2014US8853206 Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments
10/07/2014US8853203 Diazepinone derivatives
10/07/2014US8853201 Sulfate esters of noribogaine
10/07/2014US8853197 Nitrogen containing compounds
10/07/2014US8853125 Pyrazole compounds for controlling invertebrate pests
10/07/2014US8852759 Compound having acridan ring structure, and organic electroluminescent device
10/02/2014WO2014160810A1 6-(5-hydroxy-1h-pyrazol-1-yl)nicotinamide derivatives and their use as phd inhibitors
10/02/2014WO2014160692A1 2-keto amide derivatives as hiv attachment inhibitors
10/02/2014WO2014160689A1 Piperazine and homopiperazine derivatives as hiv attachment inhibitors
10/02/2014WO2014160668A1 Tetrahydroisoquinolines containing substituted azoles as factor xia inhibitors
10/02/2014WO2014160478A1 Compounds and methods for the treatment of cystic fibrosis
10/02/2014WO2014160401A1 3-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of cancer
10/02/2014WO2014160017A1 Pyridine cdk9 kinase inhibitors
10/02/2014WO2014159999A1 Cdk9 kinase inhibitors
10/02/2014WO2014159959A1 Inhibitors of human immunodeficiency virus replication
10/02/2014WO2014159353A1 Solid state forms of vemurafenib hydrochloride
10/02/2014WO2014159234A1 Glycosidase inhibitors
10/02/2014WO2014158916A1 Substituted naphthyridine and quinoline compounds as mao inhibitors
10/02/2014WO2014158528A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
10/02/2014WO2014158302A1 Novel sphingosine 1-phosphate receptor antagonists
10/02/2014WO2014157600A1 Condensed heterocyclic compound or salts thereof, agricultural and horticultural pesticide containing said compound, and method for using same
10/02/2014WO2014157569A1 Heterocyclic compound
10/02/2014WO2014157494A1 Material for organic electroluminescent elements, organic electroluminescent element, display device and lighting device
10/02/2014WO2014157437A1 Propellane derivative
10/02/2014WO2014157382A1 Sphingosine kinase inhibitor
10/02/2014WO2014154829A1 Herbicidal compounds
10/02/2014WO2014154762A1 Dihydroquinazolinone analogues as brd4 inhibitors
10/02/2014WO2014154725A1 Naphthyridine derivatives useful as alpha-v-beta-6 integrin antagonists
10/02/2014WO2014154586A1 Pyrazolonaphthyridinone derivatives as metap2 inhibitors (methionine aminopeptidase type-2)
10/02/2014WO2014154173A1 Anti-angiogenic compound
10/02/2014WO2014154168A1 Bicyclic substituted pyrimidine pde-5 inhibitor prodrug
10/02/2014WO2014154026A1 PI3K AND/OR mTOR INHIBITOR PRODRUG
10/02/2014WO2014153642A1 Synthesis of protic ionic liquids
10/02/2014US20140296530 Indolizinone based derivatives as potential phosphodiesterase 3 (pde3) inhibitors and a process for the preparation thereof
10/02/2014US20140296526 Nitrogen containing compounds and their use
10/02/2014US20140296524 Halogenated compounds for photodynamic therapy
10/02/2014US20140296283 Substituted 6,5-Fused Bicyclic Heteroaryl Compounds
10/02/2014US20140296266 Therapeutic compounds
10/02/2014US20140296265 Method of Treating Lymphoma Using Pyridopyrimidinone Inhibitors of PI3K/mTOR
10/02/2014US20140296260 3-Aryl-2-((Arylamino)Methyl)Quinazolin-4-(3H)-Ones
10/02/2014US20140296234 Pyrimidine derivatives as mtor inhibitors
10/02/2014US20140296233 Heteroaryl compounds and uses thereof
10/02/2014US20140296230 Dihydroquinazolinone analogues
10/02/2014US20140296224 Quinoline derivatives as pi3 kinase inhibitors
10/02/2014US20140296214 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
10/02/2014US20140296209 Compounds and methods for treatment of hypertension
10/02/2014US20140296204 Chemical compounds
10/02/2014US20140296203 Novel compounds that are erk inhibitors
1 ... 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 ... 646